To calculate the stabilized propensity scores, multivariable logistic regression analysis was performed with the concomitant use of dulaglutide as the dependent variable and the following independent variables: age, sex, disease duration, BMI, HbA1c, AST, ALT, eGFR, dyslipidemia, dementia, GLP-1RA treatment modality (add-on, switch or reduce), initiation of GLP-1 RA treatment (outpatient or inpatient), number of oral antidiabetic agent classes, glucose-lowering agents (none, DPP-4 inhibitors, biguanides, SGLT-2 inhibitors, insulin), insulin dose
It is not the right fit for people looking for a short-term, rapid-result solution
But theres tension here, both scientifically and culturally
For a detailed microdosing tirzepatide protocol , including concentration calculations and injection volumes, check our dedicated guide
Now they are taking 0.5 mg, double their intended dose